(2'S,16S)-5-((4S)-2,2-DIMETHYLOXAN-4-YL)-2'-METHYLSPIRO(13-OXA-1,11,14-TRIAZATETRACYCLO(7.7.0.02,7.011,15)HEXADECA-2(7),3,5,8,14-PENTAENE-16,1'-CYCLOPROPANE)-10,12-DIONE
UNII 2Y54YFZ7RJ
Substance Identification & Data
This profile provides standardized clinical and technical data for (2's,16s)-5-((4s)-2,2-dimethyloxan-4-yl)-2'-methylspiro(13-oxa-1,11,14-triazatetracyclo(7.7.0.02,7.011,15)hexadeca-2(7),3,5,8,14-pentaene-16,1'-cyclopropane)-10,12-dione, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Y54YFZ7RJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3047293-05-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H23N3O4 OZDVWCVNZHJAFO-RGDDPNHNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2's,16s)-5-((4s)-2,2-dimethyloxan-4-yl)-2'-methylspiro(13-oxa-1,11,14-triazatetracyclo(7.7.0.02,7.011,15)hexadeca-2(7),3,5,8,14-pentaene-16,1'-cyclopropane)-10,12-dione. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.